11 results on '"Badenas, C."'
Search Results
2. Reply: To PMID 25631192.
- Author
-
Tell-Martí G, Puig-Butille JA, Potrony M, Badenas C, Milà M, Malvehy J, Martí MJ, Ezquerra M, Fernández-Santiago R, and Puig S
- Subjects
- Female, Humans, Male, Genetic Predisposition to Disease genetics, Genetic Variation genetics, Melanoma genetics, Parkinson Disease genetics, Receptor, Melanocortin, Type 1 genetics
- Published
- 2015
- Full Text
- View/download PDF
3. The MC1R melanoma risk variant p.R160W is associated with Parkinson disease.
- Author
-
Tell-Marti G, Puig-Butille JA, Potrony M, Badenas C, Milà M, Malvehy J, Martí MJ, Ezquerra M, Fernández-Santiago R, and Puig S
- Subjects
- Adult, Aged, Amino Acid Sequence, Case-Control Studies, Female, Genetic Association Studies methods, Genetic Predisposition to Disease epidemiology, Humans, Male, Melanoma diagnosis, Melanoma epidemiology, Middle Aged, Molecular Sequence Data, Parkinson Disease diagnosis, Parkinson Disease epidemiology, Spain epidemiology, Genetic Predisposition to Disease genetics, Genetic Variation genetics, Melanoma genetics, Parkinson Disease genetics, Receptor, Melanocortin, Type 1 genetics
- Abstract
Epidemiological studies have reported the co-occurrence of Parkinson disease (PD) and melanoma. Common genetic variants in the MC1R (melanocortin 1 receptor) gene, which determines skin and hair color, are associated with melanoma. Here we investigated whether genetic variants in MC1R modulate the risk of PD by sequencing the entire gene in 870 PD patients and 736 controls ascertained from Spain. We found that the MC1R variant p.R160W (rs1805008) is marginally associated with PD (odds ratio = 2.10, gender- and age-adjusted p = 0.009, Bonferroni-corrected p = 0.063). Our results suggest that MC1R genetic variants modulate the risk of PD disease in the Spanish population., (© 2015 American Neurological Association.)
- Published
- 2015
- Full Text
- View/download PDF
4. Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers.
- Author
-
Cuéllar F, Puig S, Kolm I, Puig-Butille J, Zaballos P, Martí-Laborda R, Badenas C, and Malvehy J
- Subjects
- Adult, Age Factors, Dermoscopy methods, Female, Genotype, Humans, Male, Middle Aged, Pedigree, Polymerase Chain Reaction methods, Polymorphism, Genetic genetics, Skin Neoplasms ethnology, Skin Neoplasms genetics, Spain ethnology, Young Adult, Genes, p16, Genetic Variation genetics, Hair Color genetics, Melanoma ethnology, Melanoma genetics, Melanoma pathology, Receptor, Melanocortin, Type 1 genetics, Skin Neoplasms pathology
- Abstract
Background: The presence of at least one MC1R gene variant is associated with a reduction in age at melanoma diagnosis in families with CDKN2A mutations., Objectives: To describe dermoscopic features of early melanoma in CDKN2A gene mutation-positive Spanish individuals and to evaluate the possibility of a correlation between particular dermatoscopic pattern and MC1R gene variants., Methods: Patients in whom a melanoma was diagnosed during specific follow up of high-risk individuals carrying CDKN2A mutations (with familial or personal history of previous melanoma) were included in this study. The decision to remove such melanomas was taken on the basis of history, clinical and dermoscopic evaluations including total body photography and digital dermoscopy., Results: Of the nine patients included in this study, three were noncarriers of the red hair MC1R polymorphism, three patients had one red hair MC1R polymorphism and three patients had two red hair MC1R polymorphisms. On dermoscopic analysis of suspect melanocytic lesions we found that the mean +/- SD ABCD total dermoscopy score (TDS) was significantly higher in noncarriers of red hair MC1R polymorphisms than in carriers of two MC1R gene red hair variants (6.8 +/- 0.4 vs. 4.4 +/- 0.9; P = 0.014)., Conclusions: Early melanomas in patients with two MC1R red hair variants may be difficult to diagnose definitively by dermoscopy because, in our limited experience, they show fewer colours and structures and have a lower TDS. In such melanomas, subtle atypical vessels and other changes detected by digital image follow up may be useful to confirm the diagnosis of melanoma. An integrated approach including clinical history and dermoscopic data (also considering additional information, such as the presence of atypical vessels) should be utilized in evaluating these high-risk patients. Further studies are necessary to confirm our suggestion.
- Published
- 2009
- Full Text
- View/download PDF
5. X-chromosome tiling path array detection of copy number variants in patients with chromosome X-linked mental retardation.
- Author
-
Madrigal I, Rodríguez-Revenga L, Armengol L, González E, Rodriguez B, Badenas C, Sánchez A, Martínez F, Guitart M, Fernández I, Arranz JA, Tejada M, Pérez-Jurado LA, Estivill X, and Milà M
- Subjects
- Child, Child, Preschool, Chromosome Aberrations, Chromosome Mapping, Chromosomes, Artificial, Bacterial genetics, Gene Deletion, Gene Dosage, Gene Duplication, Humans, Male, Mental Retardation, X-Linked pathology, Phenotype, Sensitivity and Specificity, Chromosomes, Human, X, Genetic Variation, Mental Retardation, X-Linked diagnosis, Mental Retardation, X-Linked genetics, Microarray Analysis methods, Nucleic Acid Hybridization, Oligonucleotide Array Sequence Analysis
- Abstract
Background: Aproximately 5-10% of cases of mental retardation in males are due to copy number variations (CNV) on the X chromosome. Novel technologies, such as array comparative genomic hybridization (aCGH), may help to uncover cryptic rearrangements in X-linked mental retardation (XLMR) patients. We have constructed an X-chromosome tiling path array using bacterial artificial chromosomes (BACs) and validated it using samples with cytogenetically defined copy number changes. We have studied 54 patients with idiopathic mental retardation and 20 controls subjects., Results: Known genomic aberrations were reliably detected on the array and eight novel submicroscopic imbalances, likely causative for the mental retardation (MR) phenotype, were detected. Putatively pathogenic rearrangements included three deletions and five duplications (ranging between 82 kb to one Mb), all but two affecting genes previously known to be responsible for XLMR. Additionally, we describe different CNV regions with significant different frequencies in XLMR and control subjects (44% vs. 20%)., Conclusion: This tiling path array of the human X chromosome has proven successful for the detection and characterization of known rearrangements and novel CNVs in XLMR patients.
- Published
- 2007
- Full Text
- View/download PDF
6. Analysis of CGG variation through 642 meioses in Fragile X families.
- Author
-
Rifé M, Badenas C, Quintó L, Puigoriol E, Tazón B, Rodriguez-Revenga L, Jiménez L, Sánchez A, and Milà M
- Subjects
- Female, Genotype, Humans, Male, Mutation, Trinucleotide Repeats, Fragile X Syndrome genetics, Genetic Variation, Meiosis, Trinucleotide Repeat Expansion
- Abstract
Fragile X syndrome is the commonest familial form of inherited mental retardation. The molecular defect is an expansion of the CGG trinucleotide repeats in the 5' untranslated region of the FMR1 gene that is inherited in an unstable fashion in fragile X families. In an attempt to provide more information about the CGG tract intergenerational variation, we have evaluated 642 transmissions in 175 Fragile X families. PCR and Southern blot (StB12.3) was used to analyse the CGG number. Among premutated alleles, 90.2% showed expansion, two-thirds to a full mutation while the rest remained in the premutation range, 5.5% of alleles did not vary and finally 4.3% of them reduced in size. Premutated females showed an increased risk of expansion to the full mutation depending on the CGG tract. The estimated risk for 80 triplets is more than seven times that of a woman carrying 59 CGG, the risk being 100% for alleles of >100 repeats. Fifty-nine repeats was the smallest allele that expanded to full mutation. Contractions were detected more frequently in males than in females, being statistically significant. This study contributes to the literature by increasing the data available regarding transmissions in Fragile X families and it allows us to perform more precise genetic counselling for women with the CGG repeat in the premutation range.
- Published
- 2004
- Full Text
- View/download PDF
7. Rare variants in the promoter of the fragile X syndrome gene (FMR1).
- Author
-
Milà M, Castellví-Bel S, Sánchez A, Barceló A, Badenas C, Mallolas J, and Estivill X
- Subjects
- Adolescent, Case-Control Studies, CpG Islands, Deoxyribonucleases, Type II Site-Specific genetics, Female, Fragile X Mental Retardation Protein, Genes, Reporter, Humans, Male, Middle Aged, Nerve Tissue Proteins metabolism, Point Mutation, Promoter Regions, Genetic, Recombinant Proteins genetics, Recombinant Proteins metabolism, Trinucleotide Repeats, Fragile X Syndrome genetics, Genetic Variation, Nerve Tissue Proteins genetics, RNA-Binding Proteins
- Abstract
Fragile X syndrome, the most common form of familial mental retardation, is mainly caused by the expansion of an unstable region of CGG repeats in the 5' untranslated region of the FMR1 (Fragile X Mental Retardation-1) gene. Molecular tools to detect an abnormal CGG expansion in FMR1 include Southern blot hybridization and PCR amplification. Southern blotting with the StB12.3 probe and Eco RI/Eag I double digestion is widely used as a routine test for fragile X syndrome diagnosis in laboratories around the world. A patient with mental retardation of unknown origin showed absence of digestion for Eag I due to a -149C-->G substitution in the CpG island of the FMR1 gene, which destroys that restriction enzyme site. Screening for other changes around that region also detected a -154insGGC in a patient with a phenotype highly suggestive of fragile X syndrome but without CGG expansion. Expression studies did not show any abnormal changes in FMR1 function. In summary, we have identified two different changes (a C to G substitution at -149 and a GGC insertion at -154) in the promoter of the FMR1 gene. These are the first variants described in the promoter of the FMR1 gene., (Copyright 2000 Academic Press.)
- Published
- 2000
- Full Text
- View/download PDF
8. High‐ and intermediate‐risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium.
- Author
-
Pellegrini, C., Cardelli, L., Ghiorzo, P., Pastorino, L., Potrony, M., García‐Casado, Z., Elefanti, L., Stefanaki, I., Mastrangelo, M., Necozione, S., Aguilera, P., Rodríguez‐Hernández, A., Di Nardo, L., Rocco, T., Del Regno, L., Badenas, C., Carrera, C., Malvehy, J., Requena, C., and Bañuls, J.
- Subjects
MELANOMA ,BRAF genes ,GENETIC variation ,FAMILIES ,PANCREATIC cancer ,LOGISTIC regression analysis ,DISEASE risk factors - Abstract
Background: Most of large epidemiological studies on melanoma susceptibility have been conducted on fair skinned individuals (US, Australia and Northern Europe), while Southern European populations, characterized by high UV exposure and dark‐skinned individuals, are underrepresented. Objectives: We report a comprehensive pooled analysis of established high‐ and intermediate‐penetrance genetic variants and clinical characteristics of Mediterranean melanoma families from the MelaNostrum Consortium. Methods: Pooled epidemiological, clinical and genetic (CDKN2A, CDK4, ACD, BAP1, POT1, TERT, and TERF2IP and MC1R genes) retrospective data of melanoma families, collected within the MelaNostrum Consortium in Greece, Italy and Spain, were analysed. Univariate methods and multivariate logistic regression models were used to evaluate the association of variants with characteristics of families and of affected and unaffected family members. Subgroup analysis was performed for each country. Results: We included 839 families (1365 affected members and 2123 unaffected individuals). Pathogenic/likely pathogenic CDKN2A variants were identified in 13.8% of families. The strongest predictors of melanoma were ≥2 multiple primary melanoma cases (OR 8.1; 95% CI 3.3–19.7), >3 affected members (OR 2.6; 95% CI 1.3–5.2) and occurrence of pancreatic cancer (OR 4.8; 95% CI 2.4–9.4) in the family (AUC 0.76, 95% CI 0.71–0.82). We observed low frequency variants in POT1 (3.8%), TERF2IP (2.5%), ACD (0.8%) and BAP1 (0.3%). MC1R common variants (≥2 variants and ≥2 RHC variants) were associated with melanoma risk (OR 1.4; 95% CI 1.0–2.0 and OR 4.3; 95% CI 1.2–14.6, respectively). Conclusions: Variants in known high‐penetrance genes explain nearly 20% of melanoma familial aggregation in Mediterranean areas. CDKN2A melanoma predictors were identified with potential clinical relevance for cancer risk assessment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Synchronous primary cutaneous melanomas: a descriptive study of their clinical features, histology, genetic background of the patients and clinical outcomes.
- Author
-
Antúnez‐Lay, A., Podlipnik, S., Carrera, C., Potrony, M., Tell‐Martí, G., Badenas, C., Puig‐Butille, J.A., Espinosa, N., Puig, S., and Malvehy, J.
- Subjects
MELANOMA ,BRAF genes ,CYCLIN-dependent kinase inhibitor-2A ,OLDER patients ,HISTOLOGY ,SURVIVAL rate ,GENETIC variation ,TREATMENT effectiveness - Abstract
Background: Around 0.5% of cutaneous melanoma (CM) patients will present with synchronous melanomas when first seen. Moreover, 26–40% of patients with multiple primary melanomas present with synchronous lesions. Objectives: To assess the prevalence, clinical and histopathological characteristics, germline mutations and outcome in patients with synchronous melanoma. Methods: Clinical and histopathological data from 4703 melanoma patients were included. Clinical, histological and genetic mutational status information was analysed. Kaplan–Meier curves were used to investigate survival outcomes. Results: A total of 144 patients (3.06%) presented simultaneously with two or more primary melanomas. During follow‐up, 25.7% of patients with synchronous melanoma developed a new primary melanoma compared to 8.6% of patients diagnosed with single melanoma (P < 0.001). Germinal CDKN2A mutations were identified in 10.7% of patients with synchronous melanomas and genetic variants in MC1R in 72%. No significant differences in all survival outcomes between patients with synchronous melanomas and single melanomas were found. Conclusion: Synchronous melanomas are more frequent than previously reported and are more frequent in older patients compared to single melanomas. Moreover, these patients have a higher risk of developing a new primary melanoma during follow‐up and have higher rates of germline susceptibility variants. Nevertheless, these findings were not associated with worse outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma‐prone families from three continents
- Author
-
Goldstein, A. M., Chan, M., Harland, M., Hayward, N. K., Demenais, F., Bishop, D. T., Azizi, E., Bergman, W., Bianchi, Giovanna, Bruno, William, Calista, D., CANNON ALBRIGHT, L. A., Chaudru, V., Chompret, A., Cuellar, F., Elder, D. E., Ghiorzo, Paola, Gillanders, E. M., Gruis, N. A., Jhansson, Dhogg, Holland, E. A., Kanetsky, PETER A., Kefford, R. F., Landi, Mt, Lang, Ju, Leachman, S. A., Mackie, R. M., Magnusson, V., Mann, G. J., NEWTON BISHOP, J., Palmer, J. M., Spuig, PUIG BUTILLE, J. A., Stark, M., Tsao, H., Tucker, M. A., Whitaker, L., Yakobson, E., Malvehy, J., Badenas, C., Cervera, R., Francisco, Cuellar, Rosa, Marti´, JOAN BRUNET VIDAL, Guang, Yang, Nicholas, Martin, David, Whiteman, Adele, Green, Joanne, Aitken, Paola, Minghetti, Mantelli, Michela, Pastorino, Lorenza, Nasti, Sabina, Gargiulo, Sara, Sara, Gliori, Sushila, Mistry, JULIETTE RANDERSON MOOR, Wilma, Bergman, TER HUURNE, JEANET A. C., CLASINE VAN DER DRIFT, LENY VAN MOURIK, COBY OUT LUITING, FRANS VAN NIEUWPOORT, Valerie, Chaudru, Agnes, Chompret, Caroline, Kanengiesser, Michel, J. L., Grange, F., Sassolas, B., Limacher, J. M., Couillet, D., Truchetet, F., Cesarini, J. P., Boitier, F., CHEVRANT BRETON, J., Lasset, C., Longy, M., Joly, P., BASSET SEGUIN, N., Lesimple, T., Dugast, C., Arupa, Ganguly, Michael, Ming, PATRICIA VAN BELLE, Anton, Platz, Suzanne, Egyhazi, Rainer, Tuominen, Diana, Linden, Helen, Schmid, Alon, Scope, Felix, Pavlotsky, Eitan, Friedman, and Mark, Eliason
- Subjects
Male ,medicine.medical_specialty ,Skin Neoplasms ,Biology ,medicine.disease_cause ,Germline mutation ,CDKN2A ,Genetic variation ,Genetics ,medicine ,Humans ,Hereditary Melanoma ,neoplasms ,Melanoma ,Genetics (clinical) ,Cyclin-Dependent Kinase Inhibitor p16 ,Germ-Line Mutation ,Mutation ,Incidence (epidemiology) ,Incidence ,Australia ,Genetic Variation ,medicine.disease ,Europe ,North America ,Medical genetics ,Original Article ,Female ,Demography - Abstract
BACKGROUND: The major factors individually reported to be associated with an increased frequency of CDKN2A mutations are increased number of patients with melanoma in a family, early age at melanoma diagnosis, and family members with multiple primary melanomas (MPM) or pancreatic cancer. METHODS: These four features were examined in 385 families with > or =3 patients with melanoma pooled by 17 GenoMEL groups, and these attributes were compared across continents. RESULTS: Overall, 39% of families had CDKN2A mutations ranging from 20% (32/162) in Australia to 45% (29/65) in North America to 57% (89/157) in Europe. All four features in each group, except pancreatic cancer in Australia (p = 0.38), individually showed significant associations with CDKN2A mutations, but the effects varied widely across continents. Multivariate examination also showed different predictors of mutation risk across continents. In Australian families, > or =2 patients with MPM, median age at melanoma diagnosis or =6 patients with melanoma in a family jointly predicted the mutation risk. In European families, all four factors concurrently predicted the risk, but with less stringent criteria than in Australia. In North American families, only > or =1 patient with MPM and age at diagnosis < or =40 years simultaneously predicted the mutation risk. CONCLUSIONS: The variation in CDKN2A mutations for the four features across continents is consistent with the lower melanoma incidence rates in Europe and higher rates of sporadic melanoma in Australia. The lack of a pancreatic cancer-CDKN2A mutation relationship in Australia probably reflects the divergent spectrum of mutations in families from Australia versus those from North America and Europe. GenoMEL is exploring candidate host, genetic and/or environmental risk factors to better understand the variation observed.
- Published
- 2006
11. VP13.12: Recurrent non‐immune hydrops fetalis.
- Author
-
Soro, G., Muñoz, B., Sanchez‐Duran, M., Arevalo, S., Laura, G., and Badenas, C.
- Subjects
HYDROPS fetalis ,MULTIPLE pregnancy ,AMNIOTIC liquid ,ABORTION ,PREMATURE labor ,GENETIC variation - Abstract
Hydrops fetalis is an excessive accumulation of fetal fluid. Invasive test was offered and at 15 weeks, at the time of amniocentesis, mild hydrothorax, ascites and subcutaneous edema were present. A 30-year-old primigravida with a dichorionic-diamniotic twin pregnancy after I in vitro i fertilisation and consanguineous marriage was diagnosed of a fetal hydrops in one of the twins at the 12-week scan. [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.